St. Jude Medical
This article was originally published in The Gray Sheet
Executive Summary
U.S. clinical study begins of the Trilogy pacemaker in conjunction with a specially designed endocardial left ventricular pacing lead to treat atrial fibrillation and congestive heart failure. In the trial, which is part of a larger St. Jude program to investigate emerging indications for pacing therapy, "we aim to demonstrate that pacing the left ventricle...of the heart may have a beneficial effect on the arrhythmia itself and on several aspects of cardiac function," states lead investigator Aurelio Duran, MD, Orlando Heart Center, Florida